A389030 Share Price Performance
₩4,050.00
2611.00 (181.45%)
Price ₩4,050.00
Share Pricen/a
Is GENINUS (KOSDAQ:389030) A Risky Investment?
Dec 18
GENINUS Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A389030 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
GENINUS Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -383.68
- 1.62%
- -145.26%
- 60.8%
About A389030
- Founded
- 2018
- Employees
- 74
- CEO
- WebsiteView website
GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea. It offers CancerSCAN, an NGS-based cancer genome diagnosis solution; LiquidSCAN, a liquid biopsy NGS test; and Celinus, a single-cell analysis solution for ultra-precise genome analysis. The company also provides HealthSCAN, a genetic test service; WithMe, a service that analyzes gut bacteria characteristics related to the risk of chronic diseases; and OncoSTATION, an automated clinical genome information analysis solution. It serves hospitals, pharmaceutical companies, and researchers. The company was incorporated in 2018 and is based in Seoul, South Korea.
